Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced ...

▎药明康德内容团队编辑  结直肠癌（CRC）是全球第三大常见癌症，其死亡率不断上升。美国FDA已批准使用免疫检查点抑制剂（ICI）治疗CRC，包括PD-1抑制剂，然而超过85%具有pMMR/MSS特征的患者几乎无法从中受益。癌细胞具有高度的代谢状态， ...

Virax Biolabs enters agreement with Tebubio to expand distribution of ImmuneSelect across EU, Norway & Switzerland: London Wednesday, December 11, 2024, 17:00 Hrs [IST] Virax Biol ...

A correction has been made to Abstract, Results, 1. This sentence previously stated: “3. Neoantigen Peptides Promote CD4+, CD8+ T, and NK Cell Proliferation ... Keywords: tumor immunotherapy, tumor ...

CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...

老规矩，奇点糕开头先问大家一个问题：在激活CD8+T细胞抗肿瘤免疫应答时，有哪些细胞会起到重要作用呢？回答树突状细胞（DCs）是肯定没问题的，它们的抗原呈递功能确实广为人知，但各位要记住了，从今天开始DCs可就不是问题唯一的“正解”了。因为在今天的《 ...

1.可降解水凝胶的制备：将聚甲基丙烯酸钠（MAA）和八臂10 ...

在免疫学领域，CD8+T 细胞在抵抗病毒感染、癌症以及自身免疫疾病中扮演着至关重要的角色。 因此，准确预测 T 细胞受体（TCR，T cell receptor）与主要组织相容性复合物（MHC，Major Histocompatibility ...

在免疫学中，标记分子是用于识别和分类不同免疫细胞类型的重要工具。尽管有些分子的名称相似，但它们在结构和功能上有细微差别。下面我们将详细解析常见标记分子及其差异，帮助你更好地理解它们在免疫系统中的作用。

已经广泛证明，通过特异性抗体-抗原复合物将抗原靶向DEC-205，可以有效地摄取和呈递MHC I和MHC II复合物上的抗原，从而分别激活抗原特异性CD8+和CD4+T细胞 ... in Experimental Colitis in Mice" Eur J Microbiol Immunol (Bp) 6(1):1-8. Flow Cytometry Mitsuoka N, Iwagaki H, ...

1 Department of Computational Biology and Medical Sciences ... Major histocompatibility complex class II (MHC-II) is essential for immune surveillance within the TME. While MHC-II genes are typically ...